HudsonAlpha researchers analyzed the genomes of parents whose children were in a study of developmental delay and intellectual disability for secondary findings.
Speakers at HudsonAlpha's Genomic Medicine Conference said while sequencing results sometimes result in a diagnosis and change in care, they often have no consequence.
HudsonAlpha's Greg Barsh described results from a Clinical Sequencing Exploratory Research project during the institute's ongoing Genomic Medicine Conference.
AL.com reports Howard Jacob is leaving the HudsonAlpha Institute for Biotechnology after three years there.
The researchers will study brain samples from individuals with bipolar disorder, schizophrenia, and major depressive disorder.
The consortium aims to advance the use of genomics in the clinic, with a particular focus on diverse and underserved patient populations.
The grant will fund a collaboration investigating whether genomic signatures and other biomarkers can be used in clinical diagnosis and monitoring of kidney cancer.
At the ACMG annual conference in Phoenix last week, several labs and companies discussed their efforts in healthy genome sequencing.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.
Futurism writes that gene doping could be the next generation of cheating in sports.